further diagnostic evaluation. Collateral findings were more frequent in subjects over 50 years old compared to those of 50 years old or younger; differences were statistical significant (χ 2 = 8.42, p < 0.05). There were not statistically significant differences related to gender (χ 2 = 0.17, p > 0.05) and histology (χ 2 = 0.24, p > 0.05). Conclusion WB-MRI is an attractive procedure that allows to detect incidental abnormalities of organs not involved by disease offering the opportunity to obtain an early diagnosis of asymptomatic life-threatening diseases.
Introduction
Whole-body magnetic resonance (WB-MRI) is a non-invasive technique increasingly used to stage [1] [2] [3] [4] and followup [5] [6] [7] [8] patients with malignancies, such as lymphoproliferative disorders. It is now recognized as a promising tool that provides high-quality anatomical images and a multiparametric approach to the entire human body [9] .
Diffusion-weighted imaging with background body signal suppression (DWIBS) allows to get high-quality PETlike whole-body images [10] without contrast administration or radiation exposure.
The widespread use of WB-MRI has increased the studies [11] [12] [13] [14] [15] [16] about the incidence of collateral findings among a cohort of healthy volunteers.
The aim of this study was to describe retrospectively collateral findings detected on WB-MRI scans performed on patients with Hodgkin and Non-Hodgkin Lymphomas and to investigate if they have altered the management of these patients.
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Materials and methods
Patients
We studied 114 consecutive patients (65 male, 49 female; median age 45.2 years, range 15-86) with histologically confirmed lymphoma (47 Hodgkin, 67 Non-Hodgkin) through WB-MRI between November 2013 and December 2014. Patients underwent WB-MRI both for staging of lymphoma in a specific research protocol and to monitor the disease during and after treatment along with FDG-PET/CT.
Inclusion criteria were absence of contraindications to MRI (such as claustrophobia and implanted pacemakers or neurostimulators), histologically confirmed lymphoma, age over 14 and performance status with values from 0 to 2 according to ECOG scale (Eastern Cooperative Oncology Group).
The demographic characteristics of the study population are shown in Table 1 .
WB-MRI protocol
WB-MRI was performed by a 1.5 T (T) MR scanner (Achieva, Philips Healthcare).
No intravenous contrast agent was administered. Coronal T1-weighted (T1w) turbo spin-echo and half-Fourier multishot T2-weighted short inversion time inversion recovery (T2w-STIR) turbo spin-echo whole-body images and axial DWIBS images were acquired, using the built-in body coil (Achieva, Philips Healthcare) for signal reception. Images were acquired under free breathing, except for the stations covering the chest and the abdomen, which were acquired using breath-holding or respiratory triggering.
Sequence parameters for T1w were: repetition time (TR)/echo time (TE) of 322/18 ms, slice thickness/gap 6/1 mm, FOV of 530 × 265 mm 2 , acquisition matrix of 208 × 287, number of excitations of 1, acquired voxel size of 1.27 × 1.85 × 6.00 mm 3 , and craniocaudal coverage of 185.5 cm. WB-MRI was composed by eight stacks of coronal images performed in a total scan time of 8-10 min (1-2 min for one stack).
Parameters for T2w-STIR were: TR/TE/inversion time (IR) 1498/64/165 ms, slice thickness/gap of 6/1 mm, FOV of 530 × 265 mm 2 , acquisition matrix of 336 × 121, number of excitations of 2, acquired voxel size of 1.58 × 2.18 × 6.00 mm 3 , and craniocaudal coverage of 185.5 cm. WB-MRI was composed by eight stacks of coronal images performed in a total scan time of 9-11 min (1-2 min for one stack).
Parameters for DWIBS were: TR/TE 3134/64 ms, slice thickness/gap of 6/0 mm, FOV of 530 × 265 mm 2 , acquisition matrix of 108 × 63, number of excitations of 3, acquired voxel size of 4.91 × 4.99 × 6.00 mm 3 , craniocaudal coverage of 96 cm, and total scan time 6-8 min.
The entire total body MR imaging with three sequences was performed within 30 min, including patient positioning. The diffusion gradients of DWIBS were applied in three orthogonal directions with b = 0 and 800 s/mm 2 . High-resolution maximum intensity projection (MIP) images were reconstructed and black-white inverse greyscale was used in all cases.
Seamless coronal whole-body T1w-and T2w-STIR images were created by merging separately acquired stations using software implemented in the standard operating console. The applied WB-MRI protocol yielded a craniocaudal coverage of 185.5 cm, which was deemed to be sufficiently large to image the area from the cranial vertex to the toes in the majority of patients. However, if the patient's length exceeded 185.5 cm, the most caudal part of the body (corresponding to the patient's feet and/or distal tibiae) was not included in the image volume. Furthermore, the patient's arms were included in this WB-MRI protocol that had a (maximum) left-to-right coverage of 53.0 cm.
Whole-body MRI scan parameters are shown in Table 2 . 
Image interpretation and categorization of collateral findings
All images were retrospectively interpreted by two radiologists, respectively, with 15 and 8 years of experience in MR imaging, who were blinded to the results of other diagnostic exams. Disagreements were resolved by consensus. If the finding had not a univocal interpretation, the radiologists evaluated other available diagnostic exams performed by patients before the WB-MRI scan.
The findings detected on WB-MRI scans were considered as collateral if were not related to lymphoma.
We categorized collateral findings using the same criteria as those used by Cieszanowski et al. in a previous study [11] . Collateral findings were classified into three classes, according to their clinical significance, as follows:
• Not or low significant (class 1), if they did not require further evaluation or treatment.
• Moderately or potentially significant (class 2), if they required medical evaluation or treatment.
• Significant (class 3), if they required immediate treatment or referral to other diagnostic exams to characterize the findings.
Findings with potential or significant clinical relevance were presented to a multidisciplinary team, and the confirmation was made after medical examination and other diagnostic exams or biopsies if necessary.
Statistical analysis
The statistical analysis was performed using IBM SPSS Statistics 19.
A Chi-square (χ 2 ) test was performed to assess the statistical significance of differences in the incidence of collateral findings based on age (≤50 and >50 years old), gender, and histology (Hodgkin and Non-Hodgkin Lymphoma).
A p value of <0.05 (χ 2 > 3.84) was considered significant.
Results
Ninety-one of 114 patients (79.8 %) had one or more incidental findings on WB-MRI.
Patients with collateral findings on WB-MRI, classified into three classes according to their clinical significance, are presented in Table 3 .
Collateral findings were more frequent in class 1 (43 %), including not or low significant findings (Figs. 1, 2) . The most common single incidental findings were sinusitis and degenerative disease of the spine, both with a frequency of 25.4 % in our study population.
Abnormalities found in 35 patients (30.7 %) were considered potentially significant.
Seven patients (6.1 %) demonstrated significant collateral findings requiring immediate treatment or further diagnostic evaluation:
• Newly documented abdominal aortic aneurysm, measuring 5 cm in diameter, surgically repaired after further exams.
• Lung nodule that was proved to be an adenocarcinoma after biopsy; the same patient showed an adrenal mass characterized as adenoma through MRI of upper abdomen performed with chemical shift imaging after the whole-body scan. • Centimetric lung nodule absent in previous CT scans, too small to be characterized, with low FDG uptake on PET/CT scan (SUV 1.8) at the end of chemotherapy; unenhanced CT scan performed after 3 months documented slight size increase of the nodule that was biopsied with a diagnosis of adenocarcinoma.
• Large ovarian cyst with the longest diameter of 11 cm that was removed obtaining a diagnosis of dermoid cyst (Fig. 3 ).
• Cecal mass, highly suspicious for carcinoma, which was removed obtaining a diagnosis of cecal leiomyoma.
• Large liver mass with the longest diameter of 5 cm in a HCV-positive patient that was characterized as a Focal Nodular Hyperplasia through hepatic MRI with hepatospecific contrast agent.
• Lobar pneumonia in a patient with fever and productive cough.
WB-MRI collateral findings in the study population are presented in Table 4 .
Collateral findings of class 1 and 2 did not require further diagnostic exams to be characterized but those of class 2 required medical evaluation, treatment, or follow-up. Among those of class 3, six findings remained in this class after subsequent imaging work-up or/and histologic diagnosis, whereas two of them were downgraded. Specifically, the liver mass Computed Tomography multiplanar reconstruction on coronal view (d) performed after the WB-MRI scan. The pelvic mass was removed and was histologically characterized as a dermoid cyst characterized as Focal Nodular Hyperplasia switched to class 2, whereas the adrenal mass in the patient with lung carcinoma was characterized as adenoma and switched to class 1. We had inter-observer discordance in only three cases of class 1 (intrasellar arachnoidocele, Baker's cyst, and Tarlov cyst). The two readers were always concordant regarding to collateral findings of class 2 and 3. A statistical analysis performed to compare the frequency of collateral findings in two different age groups revealed that the great majority of them was more frequent in subjects over 50 years old compared to those of 50 years old or younger; differences were statistical significant (χ 2 = 8.42, p < 0.05). There were not statistically significant differences related to gender (χ 2 = 0.17, p > 0.05). Moreover, differences in the frequency of collateral findings on WB-MRI between patients with Hodgkin and Non-Hodgkin Lymphoma were related to the different median age between the two groups, although it was not statistically significant (χ 2 = 0.24, p > 0.05).
Discussion
The issue of collateral findings is emerging in a lot of radiologic fields, such as Cardiac, Abdominal, Neuro, Breast, and Pediatric, especially regarding MRI and CT scans [17] [18] [19] [20] [21] [22] [23] [24] [25] . The number of MRI scans has more than tripled between 1995 and 2005 [26] , and there is an unavoidable increase in detection of collateral findings [27] .
The present study estimates the frequency of collateral findings identified on WB-MRI.
To our knowledge, there are different studies evaluating collateral findings on WB-MRI that were all examining healthy general population [11] [12] [13] [14] [15] [16] . Thus, our study is the first on patients with lymphoma undergone WB-MRI.
In our study, the rate (36.8 %) of collateral findings with potential or significant clinical relevance (class 2 and 3) was in line with other studies regarding WB-MRI [13] .
There are many clinical, social, and economical advantages associated with the diagnosis of collateral findings: first, the early detection of significant disease leads to a timely treatment and improvement of prognosis; second, the occasional early diagnosis of many diseases reduces the costs for healthcare system; in addition, some of these findings turn out to be quite useful in case of surgery; finally, an extensive evaluation of patients' clinical features provides data which could be useful for a prognostic value.
However, many downstream consequences are negative, indeed, the risk is the depiction of a substantial number of incidental lesions which can not be accurately characterized on WB-MRI images, with the consequent possibility to overestimate a suspicious finding.
For this reason, it is crucial to find a balance between benefits of an early diagnosis and risks of further unnecessary investigation to protect patients from severe psychological distress. Schmidt et al. [12] analyzed the psychosocial impact of communicated incidental findings from WB-MRI concluding that disclosed incidental findings may lead to substantial psychosocial distress for patient.
A limitation of our study is the lack of a statistical comparison with previous studies performed on healthy population, but it is hard to compare the results of other studies due to different MRI systems and protocols used for image acquisition, various methods of data analysis, and absence of standardization for the classifications of detected lesions. In our study, the incidence of collateral findings (79.8 %) is lower than that previously reported by Cieszanowski et al. [11] , Lo et al. [16] , and Hegenscheid et al. [13] (>90 %). This is probably due to several factors, including the lower age of our patients (median age of 45.2 vs. 46.4 in Cieszanowski et al., 56 in Lo et al., and 53 in Hegenscheid et al.) , and this also explains the lower rate (29.1 %) of collateral findings in the study of Morin et al. [15] , where median age was 36. Another reason may be the lack of data concerning enlarged lymph nodes and splenomegaly in our classification, findings not considered as collateral in patients with lymphoma (in Cieszanowski et al. study the incidence of enlarged neck lymph nodes was 3.2 %, abdominal lymph nodes 1.5 %, and splenomegaly 1.5 %). We can conclude that the incidence of collateral findings in our study is similar to previous studies. Our findings are also consistent with those described by Cieszanowski et al. [11] of random participants in imaging research, in which the incidence of the majority of abnormalities increased with age.
There were not statistically significant differences related to gender, and these data are in line with previous studies [13, 14] .
Collateral findings detected with WB-MRI altered the management of lymphoma in two patients of our study population. Both of them had follicular lymphoma in complete remission after induction chemotherapy with R-CHOP and could not start rituximab maintenance therapy because of the diagnosis of lung adenocarcinoma.
WB-MRI is a well-established modality, especially in some diseases, such as multiple myeloma. It allows to avoid radiation exposure and contrast administration and provides images of the human body from head to toe with high spatial resolution and high sensitivity and specificity [28, 29] . Furthermore, it accurately evaluates bone marrow with an excellent reliability for marrow involvement assessment in oncologic diseases [30, 31] and also allows to identify important findings, such as osteonecrotic lesions which are very common in patients who receive chemotherapies [32] .
In conclusion, WB-MRI is a useful procedure that allows to detect collateral abnormalities of organs not involved by disease. The results of our study confirmed that collateral findings are very common and they mostly increase with age without statistically significant differences based on gender and histology. The incidental identification of diseases through WB-MRI can offer the opportunity to diagnose asymptomatic life-threatening disease earlier [33] . However, in several cases, the detection of collateral findings can also result in the identification of insignificant findings that could be stressful and harmful for patients.
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